CURI (CuriosityStream Inc. Class A Common Stock) Stock Analysis - Financials

CuriosityStream Inc. Class A Common Stock (CURI) is a publicly traded Communication Services sector company. As of May 21, 2026, CURI trades at $2.60 with a market cap of $162.74M and a P/E ratio of -20.27. CURI moved -2.99% today. Year to date, CURI is -30.67%; over the trailing twelve months it is -58.80%. Its 52-week range spans $1.47 to $7.15. Analyst consensus is strong buy with an average price target of $5.33. Rallies surfaces CURI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CURI's key financials?

CURI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CURI recently traded at $2.60. Market cap is $162.74M. P/E ratio is -20.27. Revenue is $71.73M.

CURI Key Metrics

Key financial metrics for CURI
MetricValue
Price$2.60
Market Cap$162.74M
P/E Ratio-20.27
EPS$-0.13
Dividend Yield0.09%
52-Week High$7.15
52-Week Low$1.47
Volume0
Avg Volume0
Revenue (TTM)$71.73M
Net Income$-8.07M
Gross Margin0.00%

CURI Annual Financials

YearRevenueNet IncomeEPS
2025$71.66M$-6.43M$-0.11
2024$51.13M$-12.94M$-0.24
2023$56.89M$-48.90M$-0.92
2022$78.04M$-50.92M$-0.96

Latest CURI News

Recent CURI Insider Trades

  • Hayden Phillip Brady sold 17.47K (~$65.66K) on Jan 2, 2026.
  • Hayden Phillip Brady sold 2.00K (~$9.18K) on Dec 15, 2025.
  • Cudahy Theresa Ellen sold 5.77K (~$28.70K) on Dec 10, 2025.

CURI Analyst Consensus

3 analysts cover CURI: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $5.33.

Common questions about CURI

What are CURI's key financials?
CURI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CURI recently traded at $2.60. Market cap is $162.74M. P/E ratio is -20.27. Revenue is $71.73M.
Is CURI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CURI. It does not provide personalized investment advice.
CURI

CURI